Under pathophysiological conditions, mGlu5 is overexpressed in reactive astrocytes in AD (Shrivastava et al., 2013), ALS (Aronica et al., 2001), and epilepsy (Aronica et al., 2001). This evidence concerns the gene GRM5 and Alzheimer disease.